138 related articles for article (PubMed ID: 3019205)
21. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
[TBL] [Abstract][Full Text] [Related]
22. [Pancreatic vipoma with bizarre characteristics].
Bermejo F; Moreno L; Moreira V; Gisbert JP; González Palacios F; García López JL
Gastroenterol Hepatol; 1999 Mar; 22(3):132-5. PubMed ID: 10228323
[TBL] [Abstract][Full Text] [Related]
23. Vasoactive intestinal peptide secreting tumors. Pathophysiological and clinical correlations.
Bloom SR; Yiangou Y; Polak JM
Ann N Y Acad Sci; 1988; 527():518-27. PubMed ID: 2839088
[No Abstract] [Full Text] [Related]
24. Benign pancreatic vipoma.
Alvite-Canosa M; Alonso-Fernández L; Seoane-López M; Pérz-Grobas J; Berdeal-Díaz M; Carral-Freire M; Bouzón-Alejandro A; Gómez-Dovigo A; Aguirrezabalaga-González J
Rev Esp Enferm Dig; 2011 Apr; 103(4):224-5. PubMed ID: 21526882
[No Abstract] [Full Text] [Related]
25. Islet cell tumors of the pancreas: clinico-biochemical correlations.
Khandekar JD
Ann Clin Lab Sci; 1979; 9(3):212-8. PubMed ID: 223492
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic cholera syndrome due to a vasoactive intestinal polypeptide-producing tumor: further insights into the pathophysiology.
Rood RP; DeLellis RA; Dayal Y; Donowitz M
Gastroenterology; 1988 Mar; 94(3):813-8. PubMed ID: 2828145
[TBL] [Abstract][Full Text] [Related]
27. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
[TBL] [Abstract][Full Text] [Related]
28. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
29. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
[TBL] [Abstract][Full Text] [Related]
30. [An autopsy case of WDHA syndrome].
Sakaguchi A; Tajiri T; Shima Y; Nishi S; Nishioka S; Yataka I; Gen E
Nihon Shokakibyo Gakkai Zasshi; 1982 Oct; 79(10):1991-4. PubMed ID: 6296499
[No Abstract] [Full Text] [Related]
31. Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
Granuci P; Mahler RJ
Horm Metab Res; 1982 Jun; 14(6):327-8. PubMed ID: 6288539
[No Abstract] [Full Text] [Related]
32. Multiple endocrine neoplasia, type 1, with pancreatic cholera.
Namihira Y; Achord JL; Subramony C
Am J Gastroenterol; 1987 Aug; 82(8):794-7. PubMed ID: 2886044
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cholera: is the diarrhea due to VIP?
Field M; Chang EB
N Engl J Med; 1983 Dec; 309(24):1513-5. PubMed ID: 6316137
[No Abstract] [Full Text] [Related]
34. [Plasma vasoactive intestinal polypeptide assay and the clinical significance].
Yamaguchi K; Otsubo K; Haniuda C; Miyoshi S; Abe K; Ohnami S
Nihon Rinsho; 1990 Feb; 48 Suppl():43-7. PubMed ID: 2162430
[No Abstract] [Full Text] [Related]
35. Islet cell carcinoma, pancreatic cholera, and vasoactive intestinal peptide.
Graham DY; Johnson CD; Bentlif PS; Kelsey JR
Ann Intern Med; 1975 Dec; 83(6):782-5. PubMed ID: 173221
[TBL] [Abstract][Full Text] [Related]
36. Influence of cholecystokinin, vasoactive intestinal peptide and secretin on plasma concentration of avian pancreatic polypeptide in laying hens.
Duke GE; Kimmel JR; Hunt H; Pollock HG; Mosher JA
Comp Biochem Physiol A Comp Physiol; 1986; 85(2):347-50. PubMed ID: 2876840
[TBL] [Abstract][Full Text] [Related]
37. Primary Pancreatic Secretinoma: Further Evidence Supporting Secretin as a Diarrheogenic Hormone.
Chey WY; Frankel WL; Roy S; Datta S; Sen CK; Dillhoff M; Muscarella P; Soergel KH; Tompkins RK; Chang TM; Bradley EL; Ellison EC
Ann Surg; 2017 Aug; 266(2):346-352. PubMed ID: 27501174
[TBL] [Abstract][Full Text] [Related]
38. Increased tear secretion in pancreatic cholera: a newly recognized symptom in an experiment of nature.
Gilbard JP; Dartt DA; Rood RP; Rossi SR; Gray KL; Donowitz M
Am J Med; 1988 Oct; 85(4):552-4. PubMed ID: 2845780
[No Abstract] [Full Text] [Related]
39. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
40. [Gastrointestinal hormones: present status].
Klapdor R
Med Lab (Stuttg); 1979 Apr; 32(4):71-88. PubMed ID: 220513
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]